IL130765A0 - Formulation of stabilised cationic transfection agent(s)/ nucleic acid particles - Google Patents

Formulation of stabilised cationic transfection agent(s)/ nucleic acid particles

Info

Publication number
IL130765A0
IL130765A0 IL13076598A IL13076598A IL130765A0 IL 130765 A0 IL130765 A0 IL 130765A0 IL 13076598 A IL13076598 A IL 13076598A IL 13076598 A IL13076598 A IL 13076598A IL 130765 A0 IL130765 A0 IL 130765A0
Authority
IL
Israel
Prior art keywords
nucleic acid
transfection agent
formulation
acid particles
cationic transfection
Prior art date
Application number
IL13076598A
Other languages
English (en)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9503492&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL130765(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of IL130765A0 publication Critical patent/IL130765A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL13076598A 1997-02-10 1998-02-06 Formulation of stabilised cationic transfection agent(s)/ nucleic acid particles IL130765A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701467A FR2759298B1 (fr) 1997-02-10 1997-02-10 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees
PCT/FR1998/000222 WO1998034648A1 (fr) 1997-02-10 1998-02-06 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees

Publications (1)

Publication Number Publication Date
IL130765A0 true IL130765A0 (en) 2001-01-28

Family

ID=9503492

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13076598A IL130765A0 (en) 1997-02-10 1998-02-06 Formulation of stabilised cationic transfection agent(s)/ nucleic acid particles

Country Status (20)

Country Link
EP (1) EP1007097B1 (de)
JP (1) JP2001511171A (de)
KR (1) KR20000070914A (de)
AT (1) ATE206932T1 (de)
AU (1) AU737720B2 (de)
BR (1) BR9807563A (de)
CA (1) CA2278665A1 (de)
CZ (1) CZ282199A3 (de)
DE (1) DE69802102T2 (de)
DK (1) DK1007097T3 (de)
ES (1) ES2166146T3 (de)
FR (1) FR2759298B1 (de)
GR (1) GR3036919T3 (de)
HU (1) HUP0001720A3 (de)
IL (1) IL130765A0 (de)
NO (1) NO993825D0 (de)
PT (1) PT1007097E (de)
SK (1) SK282685B6 (de)
WO (1) WO1998034648A1 (de)
ZA (1) ZA981034B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6359054B1 (en) * 1994-11-18 2002-03-19 Supratek Pharma Inc. Polynucleotide compositions for intramuscular administration
JP2002511446A (ja) * 1998-04-08 2002-04-16 セルテック・セラピューティクス・リミテッド 脂 質
CA2335393C (en) * 1998-07-20 2008-09-23 Inex Pharmaceuticals Corporation Liposomal encapsulated nucleic acid-complexes
BR0108959A (pt) * 2000-03-03 2003-10-14 Valentis Inc Composições de polox‰mero ou poloxamina melhoradas para distribuição de ácido nucléico
GB0009201D0 (en) * 2000-04-14 2000-05-31 Univ Nottingham Cationic polymer - Nucleic acid complexes and methods of making them
US20020091242A1 (en) 2000-10-11 2002-07-11 Michel Bessodes Acid-sensitive compounds, their preparation and uses
ATE503463T1 (de) * 2000-10-20 2011-04-15 Vical Inc Gen-abgabeformulierungen zur behandlung ischämischer zustände
EP1232758A1 (de) * 2001-02-19 2002-08-21 Aventis Pasteur Polynukleotid-Formulierung für verbesserte intrazellulare Übertragung
CA2558676C (en) 2004-03-03 2019-04-16 Essentia Biosystems, Inc. Compositions and methods for topical diagnostic and therapeutic transport
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
ZA200707352B (en) 2005-03-03 2009-04-29 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of botulinum toxins
JP4653242B1 (ja) 2010-02-12 2011-03-16 ナノキャリア株式会社 粒子状医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1181937A3 (de) * 1994-08-09 2004-02-04 Cytrx Corporation Nukleinsäure enthaltender Impfstoff, Impfstoff-adjuvans
AU5527696A (en) * 1995-03-31 1996-10-16 Children's Hospital Medical Center Use of surfactants for introducing genetic material into lun g cells
US6120794A (en) * 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells

Also Published As

Publication number Publication date
FR2759298A1 (fr) 1998-08-14
SK282685B6 (sk) 2002-11-06
HUP0001720A3 (en) 2001-10-29
DE69802102T2 (de) 2002-03-14
EP1007097A1 (de) 2000-06-14
AU737720B2 (en) 2001-08-30
ES2166146T3 (es) 2002-04-01
PT1007097E (pt) 2002-04-29
ZA981034B (en) 1998-08-11
NO993825L (no) 1999-08-09
CA2278665A1 (fr) 1998-08-13
CZ282199A3 (cs) 1999-10-13
FR2759298B1 (fr) 1999-04-09
EP1007097B1 (de) 2001-10-17
HUP0001720A1 (hu) 2000-09-28
NO993825D0 (no) 1999-08-09
GR3036919T3 (en) 2002-01-31
JP2001511171A (ja) 2001-08-07
SK108299A3 (en) 2000-05-16
WO1998034648A1 (fr) 1998-08-13
KR20000070914A (ko) 2000-11-25
DE69802102D1 (de) 2001-11-22
AU6298798A (en) 1998-08-26
DK1007097T3 (da) 2002-02-11
ATE206932T1 (de) 2001-11-15
BR9807563A (pt) 2000-02-01

Similar Documents

Publication Publication Date Title
GR3036919T3 (en) Formulation of stabilised cationic transfection agent(s)/nucleic acid particles
EP0911039A3 (de) Wirkstoff-Harzkomplexe stabilisiert mit Chelatbildner
IL115742A (en) Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
HK1042444A1 (zh) 藥用噴霧製劑
IL172835A0 (en) A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids
ZA98792B (en) Bar compositions comprising adjuvant powders for delivering benefit agent and process for the manufacture of said bars.
HK1028548A1 (en) Formulations for hydrophobic pharmaceutical agents
AU3438900A (en) Use of trehalose for stabilising a liquid vaccine
MX9804848A (es) Emulsiones estables que comprenden un ingrediente liquido hidrofobico.
WO2000032186A3 (en) Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
EP1053010A4 (de) Copolymer-zusammensetzungen zur oralen verabreichung
CA2194979A1 (en) Solid drug forms containing clathrates of steroid sex hormones
WO2000050046A8 (en) Stabilized oral pharmaceutical composition containing iodide and iodate and method
HUP9900475D0 (en) O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
AU3868997A (en) Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
YU8701A (sh) Nova oralna kompozicija
AU1869601A (en) Pharmaceutical compositions comprising trimegestone
BR9811985A (pt) Dispositivo de dosagem
WO1998023260A3 (en) Non-ionic surfactant vesicles as a delivery agent for nucleic acid
WO1998023297A3 (en) Particulate compositions
EP0891778A3 (de) Mittel für Vorbeugung und/oder Behandlung von strahlungsinduzierter Störungen
MX9706067A (es) Composiciones liquidas que contienen tensoactivos alquil poliglicosidos para la limpieza industrial e institucional.
MX9708160A (es) Composicion y aparato para la limpieza de superficies.
MX9603741A (es) Composicion de liberacion mantenida.
MX9706089A (es) Composiciones para el cuidado personal y productos de limpiadura que contienen las composiciones.